Opendata, web and dolomites

SWEET CROSSTALK SIGNED

Training interdisciplinary glycoscientists to get a molecular-level grip on glycocodes at the human mucosa–microbiota interface

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SWEET CROSSTALK project word cloud

Explore the words cloud of the SWEET CROSSTALK project. It provides you a very rough idea of what is the project "SWEET CROSSTALK" about.

outstanding    disease    fundamental    drives    understand    expert    platform    cell    structural    microbiology    arrived    healthcare    equip    private    leaders    intersectoral    credibility    job    interdisciplinary    public    whereas    entire    therapies    strategy    modulate    biology    host    crosstalk    covers    stage    ranging    complementary    training    dominate    innovative    time    glycotherapeutics    partnership    ideally    microbiota    excellence    diagnostics    network    paradigm    health    quality    groups    combination    interactions    academic    grip    chemical    human    positioned    correlates    smart    optimal    ensured    sweet    glycans    microbiome    interface    synergy    proteins    renowned    mucosa    obtaining    skills    transferable    competitive    biotech    prophylactic    scientific    specialized    directs    chemistry    biochemistry    glycocodes    industry    smes    glycan    international    reshaped    market    interacting    generation    expertise    multidisciplinary    molecular    train    glycoscience    scientists    synthesis    15   

Project "SWEET CROSSTALK" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITEIT UTRECHT 

Organization address
address: HEIDELBERGLAAN 8
city: UTRECHT
postcode: 3584 CS
website: www.uu.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 4˙117˙674 €
 EC max contribution 4˙117˙674 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2018
 Funding Scheme MSCA-ITN-ETN
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITEIT UTRECHT NL (UTRECHT) coordinator 531˙239.00
2    QUADRAM INSTITUTE BIOSCIENCE UK (NORWICH) participant 606˙345.00
3    HELSINGIN YLIOPISTO FI (HELSINGIN YLIOPISTO) participant 561˙611.00
4    UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II IT (NAPOLI) participant 522˙999.00
5    ICENI DIAGNOSTICS LIMITED UK (NORWICH) participant 303˙172.00
6    GLYCOM AS DK (HORSHOLM) participant 297˙522.00
7    NUTRILEADS BV NL (WAGENINGEN) participant 265˙619.00
8    UNIVERSITEIT LEIDEN NL (LEIDEN) participant 265˙619.00
9    INBIOSE NV BE (GENT) participant 256˙320.00
10    UNIVERSITE CATHOLIQUE DE LOUVAIN BE (LOUVAIN LA NEUVE) participant 256˙320.00
11    UNIVERSITAT DE BARCELONA ES (BARCELONA) participant 250˙904.00
12    DANMARKS TEKNISKE UNIVERSITET DK (KGS LYNGBY) partner 0.00
13    UNIVERSITEIT GENT BE (GENT) partner 0.00
14    UNIVERSITY OF EAST ANGLIA UK (NORWICH) partner 0.00

Map

 Project objective

Sweet Crosstalk is a multidisciplinary European Training Network built to address the challenge of understanding, at a molecular level, how glycans are involved at the human mucosa–microbiota interface, and how this correlates with human well-being. Research into the human microbiome has reshaped the paradigm of our health and disease. In order to advance further, the time has arrived to understand it at a molecular level. Glycans dominate the microbiota-host interface and are thus ideally positioned to modulate these complex interactions. The research strategy of the Sweet Crosstalk programme focuses on optimal synergy between chemistry and biology. Smart chemistry drives the research to get a molecular-level grip on the role of these glycocodes and their interacting proteins, and advances in biology directs the research. The high quality and credibility of our consortium is ensured by a strong private-public partnership with complementary expertise ranging from chemical synthesis, biochemistry, structural biology to microbiology and cell biology. Our 7 academic groups are all renowned leaders in the glycoscience and microbiome fields, whereas the complementary 4 SMEs are specialized in glycan-based diagnostics and prophylactic therapies. This unique combination of scientific excellence and industry know-how covers the entire process from obtaining fundamental insight to the development of innovative early diagnostics and glycotherapeutics. Sweet Crosstalk also represents a unique research platform to train 15 outstanding Early Stage Researchers to be the new generation of innovative scientists with expert knowledge and skills in interdisciplinary glycoscience and human microbiome research. Our international, intersectoral and interdisciplinary training programme will equip them with the necessary scientific and transferable skills that will make them highly competitive for both top European research institutions and the healthcare/biotech job market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SWEET CROSSTALK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SWEET CROSSTALK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

BIGMATH (2018)

Big Data Challenges for Mathematics

Read More  

NanoCarb (2018)

Glyco-Nanoparticles for Applications in Advance Nanomedicine

Read More  

ElectroPros (2019)

Training research pioneers by utilizing and validating the promise of electroporation for minimal invasive oncological treatments.

Read More